CCL5 and neuromyelitis optica: The proteasome inhibitor MG132 blocked more than 95 % of the CCL5 response induced by stimulation with NMO IgG for 24 h and effectively reduced CCL2 and CXCL1 production at levels exceeding tenfold inhibition.